(0.51%) 5 214.08 points
(0.85%) 39 388 points
(0.27%) 16 346 points
(0.66%) $79.78
(1.39%) $2.33
(0.76%) $2 358.20
(0.72%) $28.57
(0.31%) $993.90
(0.07%) $0.928
(-0.10%) $10.86
(0.06%) $0.799
(0.17%) $92.70
@ $82.43
発行日: 10 5月 2024 @ 04:00
リターン: 0.36%
前回のシグナル: 5月 10 - 00:19
前回のシグナル:
リターン: 0.40 %
Live Chart Being Loaded With Signals
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, Hong Kong, and internationally...
Stats | |
---|---|
本日の出来高 | 1.95M |
平均出来高 | 3.57M |
時価総額 | 37.76B |
EPS | $0 ( 2024-04-30 ) |
次の収益日 | ( $0.970 ) 2024-07-23 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 24.05 |
ATR14 | $1.450 (1.75%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-05-01 | Jimenez Frank R | Buy | 1 315 | Common Stock, par value $0.01 per share |
2024-04-01 | Rott Roland | Sell | 837 | Common Stock, par value $0.01 per share |
2024-03-15 | General Electric Co | Sell | 14 000 000 | Common stock, par value $0.01 per share |
2024-03-01 | Westrick Thomas J. | Sell | 1 195 | Common Stock, par value $0.01 per share |
2024-03-01 | Westrick Thomas J. | Sell | 1 285 | Common Stock, par value $0.01 per share |
INSIDER POWER |
---|
-97.67 |
Last 99 transactions |
Buy: 735 929 | Sell: 57 991 119 |
ボリューム 相関
GE HealthCare 相関
10 最も正の相関 |
---|
10 最も負の相関 |
---|
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
GE HealthCare 相関 - 通貨/商品
GE HealthCare 財務諸表
Annual | 2023 |
収益: | $19.55B |
総利益: | $7.92B (40.52 %) |
EPS: | $3.04 |
FY | 2023 |
収益: | $19.55B |
総利益: | $7.92B (40.52 %) |
EPS: | $3.04 |
FY | 2022 |
収益: | $18.34B |
総利益: | $7.18B (39.14 %) |
EPS: | $4.22 |
FY | 2021 |
収益: | $17.59B |
総利益: | $7.17B (40.80 %) |
EPS: | $4.94 |
Financial Reports:
No articles found.
GE HealthCare
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, Hong Kong, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, and X-ray systems, as well as women's health products. The Ultrasound segment provides screening, diagnosis, treatment, and monitoring of certain diseases through radiology and primary care, women's health, cardiovascular, and point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products. The Patient Care Solutions segment involved in the provision of medical devices, consumable products, services, and digital solutions through patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, and maternal infant care products. The Pharmaceutical Diagnostics supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound to the radiology and nuclear medicine industry. The segment also provides contrast media pharmaceuticals, administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents, or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes that are injected into a patient prior to a diagnostic imaging scan. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。